Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2025
Acquired high tumor mutational burden and activity of immunotherapy after targeted therapy in microsatellite stable colorectal cancer
Celine Yeh, Oliver Artz, Haochen Zhang, et al.
JAMA Oncology
|
September 5, 2024
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer
Catherine A O'Connor, Emily Harrold, David Lin, et al.
Current Oncology (Toronto, Ont.)
|
March 27, 2024
Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland
Lynda M McSorley, Mehala Tharmabala, Fathiya Al Rahbi, et al.
Journal of the National Cancer Institute
|
June 13, 2025
Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma
Fergus Keane, Lily V Saadat, Catherine A O'Connor, et al.
The Oncologist
|
June 28, 2024
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy
Darren Cowzer, Joanne F Chou, Henry Walch, et al.
NPJ Precision Oncology
|
February 7, 2026
Dual pancreatic carcinomas: clonally related or independent primaries?
Joshua D Schoenfeld, Vignesh Ravichandran, Zeynep Tarcan, et al.
Journal of the National Cancer Institute
|
October 26, 2024
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort
Fergus Keane, Catherine O'Connor, Drew Moss, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer
Wungki Park, Shigeaki Umeda, Marc Hilmi, et al.
Nature Medicine
|
October 16, 2023
Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade
Emily C Harrold, Michael B Foote, Benoit Rousseau, et al.
Research Square
|
September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial
Wungki Park, Catherine O'Connor, Joanne Chou, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2025
Acquired high tumor mutational burden and activity of immunotherapy after targeted therapy in microsatellite stable colorectal cancer
Celine Yeh, Oliver Artz, Haochen Zhang, et al.
JAMA Oncology
|
September 5, 2024
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer
Catherine A O'Connor, Emily Harrold, David Lin, et al.
Current Oncology (Toronto, Ont.)
|
March 27, 2024
Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland
Lynda M McSorley, Mehala Tharmabala, Fathiya Al Rahbi, et al.
Journal of the National Cancer Institute
|
June 13, 2025
Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma
Fergus Keane, Lily V Saadat, Catherine A O'Connor, et al.
The Oncologist
|
June 28, 2024
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy
Darren Cowzer, Joanne F Chou, Henry Walch, et al.
NPJ Precision Oncology
|
February 7, 2026
Dual pancreatic carcinomas: clonally related or independent primaries?
Joshua D Schoenfeld, Vignesh Ravichandran, Zeynep Tarcan, et al.
Journal of the National Cancer Institute
|
October 26, 2024
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort
Fergus Keane, Catherine O'Connor, Drew Moss, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer
Wungki Park, Shigeaki Umeda, Marc Hilmi, et al.
Nature Medicine
|
October 16, 2023
Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade
Emily C Harrold, Michael B Foote, Benoit Rousseau, et al.
Research Square
|
September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial
Wungki Park, Catherine O'Connor, Joanne Chou, et al.
Page
of 4